Lupin Introduces First Generic Version of Pred Forte in US
Being the first generic to be approved and launched, the company is entitled to 180-day competitive generic therapy (CGT) exclusivity.
Prednisolone Acetate Ophthalmic Suspension | 16/10/2024 | By Aishwarya
Lupin Gets Approval from US FDA for Prednisolone Acetate Ophthalmic Suspension
Lupin has secured approval from US FDA for its Abbreviated New Drug Application (ANDA) for Prednisolone Acetate Ophthalmic Suspension USP, 1 percent to market a generic equivalent of Pred Forte Ophthalmic Suspension, 1 percent, of AbbVie Inc.
Prednisolone Acetate Ophthalmic Suspension | 07/08/2024 | By Aishwarya | 146
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy